Atlas Arteria (ASX:ALX) Growth Rank: 8 (As of Aug. 05, 2026) — 14% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:ALX Atlas Arteria Ltd ASX:ALX
77 GF Score
Price A$4.99
GF Value A$5.88
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Atlas Arteria Growth Rank?

Atlas Arteria ASX:ALX -1.19% 77 Growth Rank is 8 as of Aug. 05, 2026, which is 14% above its 10-year median of 7.00. GuruFocus rates ASX:ALX with a GF Score™ of 77/100 and a GF Value™ of A$5.88 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Atlas Arteria has the Growth Rank of 8.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Atlas Arteria Growth Rank Competitor Comparison

For the Infrastructure Operations subindustry, Atlas Arteria's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Atlas Arteria Growth Rank vs Construction Industry

For the Construction industry and Industrials sector, Atlas Arteria's Growth Rank distribution charts can be found below:

* The bar in red indicates where Atlas Arteria's Growth Rank falls into.


ASX:ALX
77GF Score
Atlas Arteria Ltd ASX:ALX
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Growth Rank →
What does a Growth Rank of 8 mean?
Atlas Arteria (ASX:ALX) has a Growth Rank of 8 as of Aug. 05, 2026. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Atlas Arteria and its competitors. This is 14% above median its historical median of 7.00. Over the past decade, Atlas Arteria's Growth Rank has ranged from 1.00 to 8.00.
Is Atlas Arteria's Growth Rank too high?
Atlas Arteria's current Growth Rank of 8 is 14% above median its 10-year median of 7.00. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 8.00. Overall, Atlas Arteria has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Atlas Arteria's Growth Rank compare to competitors?
Atlas Arteria's Growth Rank of 8 can be compared against companies in the Construction industry. Historically, Atlas Arteria's own Growth Rank has ranged from 1.00 to 8.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Growth Rank for a Construction company?
A good Growth Rank depends on the Construction industry context. However, Growth Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Growth Rank mean?
A high Growth Rank can signal that a stock is expensive relative to its fundamentals. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Atlas Arteria and its competitors. Atlas Arteria's current Growth Rank is 8, which is 14% above median its own 10-year median of 7.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Atlas Arteria stock overvalued right now?
Based on GuruFocus' analysis, Atlas Arteria (ASX:ALX) is currently considered Modestly Undervalued. The stock's GF Value™ is A$5.88, compared to a current price of A$4.99 — trading 15.1% below its estimated fair value. The current Growth Rank is 8, which is 14% above median its 10-year median of 7.00. Atlas Arteria's overall GF Score™ is 77/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Growth Rank calculated?
Growth Rank is calculated from a company's financial statements. For Atlas Arteria (ASX:ALX), the current Growth Rank is 8 as of Aug. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Atlas Arteria (ASX:ALX) Overvalued in 2026?

Based on GuruFocus' analysis, Atlas Arteria stock appears to be undervalued. The current stock price of A$4.99 is trading 15.1% below its estimated GF Value™ of A$5.88. GuruFocus considers Atlas Arteria to be Modestly Undervalued.

Key valuation signals for ASX:ALX:

  • Growth Rank: 8 (14% above median its 10-year median of 7.00)
  • GF Value™: A$5.88 vs. price of A$4.99 (15.1% below fair value)
  • GF Score™: 77/100 with 5 warning signs

No single metric tells the full story. See the ASX:ALX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Atlas Arteria Business Description

Other Exchanges MAQAF:USAM82:Germany
Address 180 Flinders Street, Level 1, Melbourne, VIC, AUS, 3000
Atlas Arteria is a global toll-road investor created out of the reorganization of Macquarie Infrastructure Group in 2010. The firm's main asset is a 30.82% stake in APRR. APRR owns concessions to toll more than 2,300 kilometers of motorways in eastern France, most ending by late 2035. The firm also wholly owns the Dulles Greenway and 66.67% of the Chicago Skyway, both in the US.
77GF Score

Get the complete analysis for ASX:ALX

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$4.99
Price
A$5.88
GF Value